Anthony Petrone
Stock Analyst at Mizuho
(3.66)
# 773
Out of 5,241 analysts
226
Total ratings
46.99%
Success rate
7.45%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Maintains: Neutral | $22 → $27 | $32.07 | -15.81% | 9 | May 14, 2026 | |
| LNTH Lantheus Holdings | Maintains: Outperform | $95 → $100 | $93.91 | +6.48% | 10 | May 8, 2026 | |
| MNKD MannKind | Maintains: Outperform | $8 → $7 | $3.09 | +126.54% | 2 | May 7, 2026 | |
| LIVN LivaNova | Maintains: Outperform | $85 → $90 | $70.00 | +28.57% | 11 | May 7, 2026 | |
| ALC Alcon | Maintains: Outperform | $95 → $85 | $63.64 | +33.56% | 12 | May 7, 2026 | |
| ADMA ADMA Biologics | Maintains: Outperform | $24 → $20 | $8.27 | +141.84% | 8 | May 7, 2026 | |
| EMBC Embecta | Maintains: Neutral | $12 → $5 | $3.14 | +59.24% | 5 | May 6, 2026 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $70 → $55 | $40.05 | +37.33% | 10 | May 5, 2026 | |
| MDT Medtronic | Maintains: Outperform | $125 → $120 | $76.15 | +57.58% | 8 | Apr 13, 2026 | |
| ISRG Intuitive Surgical | Maintains: Neutral | $575 → $525 | $421.12 | +24.67% | 7 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $70 | $56.29 | +24.36% | 18 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $90 | $60.76 | +48.12% | 7 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $95 | $81.38 | +16.74% | 11 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $90 | $52.68 | +70.84% | 10 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $21 | $10.80 | +94.44% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $100 | $65.76 | +52.07% | 10 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $22 | $12.82 | +71.61% | 3 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $78 → $90 | $61.63 | +46.03% | 4 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $3.57 | +180.50% | 5 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $120 | $94.92 | +26.42% | 4 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $100 | $59.61 | +67.76% | 16 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $40.99 | -2.42% | 1 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $300 | $201.88 | +48.60% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $135 | $129.71 | +4.08% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $140 → $135 | $84.47 | +59.82% | 6 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $200 → $175 | $144.01 | +21.52% | 10 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $5.77 | +593.24% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $58 | $62.48 | -7.17% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $97.31 | -31.15% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $83.70 | +109.08% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $9.66 | +158.80% | 3 | May 13, 2020 |
STAAR Surgical Company
May 14, 2026
Maintains: Neutral
Price Target: $22 → $27
Current: $32.07
Upside: -15.81%
Lantheus Holdings
May 8, 2026
Maintains: Outperform
Price Target: $95 → $100
Current: $93.91
Upside: +6.48%
MannKind
May 7, 2026
Maintains: Outperform
Price Target: $8 → $7
Current: $3.09
Upside: +126.54%
LivaNova
May 7, 2026
Maintains: Outperform
Price Target: $85 → $90
Current: $70.00
Upside: +28.57%
Alcon
May 7, 2026
Maintains: Outperform
Price Target: $95 → $85
Current: $63.64
Upside: +33.56%
ADMA Biologics
May 7, 2026
Maintains: Outperform
Price Target: $24 → $20
Current: $8.27
Upside: +141.84%
Embecta
May 6, 2026
Maintains: Neutral
Price Target: $12 → $5
Current: $3.14
Upside: +59.24%
Inspire Medical Systems
May 5, 2026
Maintains: Outperform
Price Target: $70 → $55
Current: $40.05
Upside: +37.33%
Medtronic
Apr 13, 2026
Maintains: Outperform
Price Target: $125 → $120
Current: $76.15
Upside: +57.58%
Intuitive Surgical
Apr 13, 2026
Maintains: Neutral
Price Target: $575 → $525
Current: $421.12
Upside: +24.67%
Apr 13, 2026
Maintains: Outperform
Price Target: $80 → $70
Current: $56.29
Upside: +24.36%
Apr 13, 2026
Maintains: Outperform
Price Target: $95 → $90
Current: $60.76
Upside: +48.12%
Apr 13, 2026
Maintains: Outperform
Price Target: $100 → $95
Current: $81.38
Upside: +16.74%
Apr 13, 2026
Maintains: Outperform
Price Target: $115 → $90
Current: $52.68
Upside: +70.84%
Mar 31, 2026
Initiates: Outperform
Price Target: $21
Current: $10.80
Upside: +94.44%
Feb 25, 2026
Maintains: Outperform
Price Target: $90 → $100
Current: $65.76
Upside: +52.07%
Feb 20, 2026
Maintains: Neutral
Price Target: $21 → $22
Current: $12.82
Upside: +71.61%
Feb 13, 2026
Maintains: Outperform
Price Target: $78 → $90
Current: $61.63
Upside: +46.03%
Dec 17, 2025
Maintains: Outperform
Price Target: $12 → $10
Current: $3.57
Upside: +180.50%
Dec 17, 2025
Maintains: Outperform
Price Target: $100 → $120
Current: $94.92
Upside: +26.42%
Dec 5, 2025
Maintains: Outperform
Price Target: $85 → $100
Current: $59.61
Upside: +67.76%
Dec 1, 2025
Initiates: Outperform
Price Target: $40
Current: $40.99
Upside: -2.42%
Oct 31, 2025
Maintains: Outperform
Price Target: $310 → $300
Current: $201.88
Upside: +48.60%
Aug 1, 2025
Maintains: Neutral
Price Target: $130 → $135
Current: $129.71
Upside: +4.08%
Jul 18, 2025
Maintains: Neutral
Price Target: $140 → $135
Current: $84.47
Upside: +59.82%
Apr 16, 2025
Maintains: Outperform
Price Target: $200 → $175
Current: $144.01
Upside: +21.52%
Apr 10, 2025
Initiates: Outperform
Price Target: $40
Current: $5.77
Upside: +593.24%
Mar 6, 2025
Maintains: Buy
Price Target: $54 → $58
Current: $62.48
Upside: -7.17%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $97.31
Upside: -31.15%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $83.70
Upside: +109.08%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $9.66
Upside: +158.80%